Christopher R. Smith

Identification of MRTX1133, a Noncovalent, Potent, and Selective KRAS ^G12D Inhibitor

Xiaolun Wang, Shelley Allen, James F. Blake et al. · Journal of Medicinal Chemistry · 2021 · 644 citations · Full text

Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor

Jill Hallin, Vickie Bowcut, Andrew Calinisan et al. · Nature Medicine · 2022 · 465 citations

Medicine, Pharmacology, Pharmacotherapy +7

Integrating de novo and inherited variants in 42,607 autism cases identifies mutations in new moderate-risk genes

Xueya Zhou, Pamela Feliciano, Chang Shu et al. · Nature Genetics · 2022 · 423 citations · Full text

Mining biomarkers in human sera using proteomic tools

Rulin Zhang, Lisa Barker, Deborah Pinchev et al. · PROTEOMICS · 2004 · 186 citations

Low Abundance Proteins, Protein Purification, Proteomic Technology +23

Sigma 2 receptors as potential biomarkers of proliferation in breast cancer.

Robert H. Mach, Christopher R. Smith, Isaf Al‐Nabulsi et al. · PubMed · 1997 · 177 citations

Tumor Biology, Sigma Receptors, Breast Oncology +15